A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
NextCure, Inc.
NextCure, Inc.
Servier
Mustang Bio
Prelude Therapeutics
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
University of Rochester
Merck Sharp & Dohme LLC
Stanford University
Columbia University
University of South Florida
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute